Cardiac tissue engineering using human stem cell-derived cardiomyocytes for disease modeling and drug discovery

Drug Discovery Today: Disease Models

Volumn 9, Issue 4, 2012, Pages

  Turnbull, Irene C ^a   Lieu, Deborah K ^a,b   Li, Ronald A ^a,c,d   Costa, Kevin D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTININ 2; ELASTOMER; TROPONIN T;

ARTICLE; BIOMIMETICS; CARDIAC TISSUE ENGINEERING; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; COLD INJURY; CONGESTIVE CARDIOMYOPATHY; DISEASE MODEL; DRUG SCREENING; ELECTROPHYSIOLOGY; ELECTROSTIMULATION; EMBRYONIC STEM CELL; EYE TRACKING; FUNCTIONAL ASSESSMENT; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; HUMAN; HUMAN CELL; LEOPARD SYNDROME; MESENCHYMAL STEM CELL; MICROELECTROMECHANICAL SYSTEM; PATHOPHYSIOLOGY; PLURIPOTENT STEM CELL; REGENERATIVE MEDICINE; SCAR FORMATION; STARLING LAW; TISSUE ENGINEERING;

EID: 84876675545     PISSN: None     EISSN: 17406757     Source Type: Journal    
DOI: 10.1016/j.ddmod.2012.11.001     Document Type: Review

References (68)

1. V.L. Roger Executive summary: heart disease and stroke statistics-2012 update: a report from the American Heart Association Circulation 125 2012 188 197
2. P. Menasche The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation Circulation 117 2008 1189 1200
3. J.S. Ross Pooled analysis of rofecoxib placebo-controlled clinical trial data: lessons for postmarket pharmaceutical safety surveillance Arch. Intern. Med. 169 2009 1976 1985
4. L. Yang Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population Nature 453 2008 524 528
5. P.W. Burridge A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability PLoS ONE 6 2011 e18293
6. J.D. Fu Na+/Ca2+ exchanger is a determinant of excitation-contraction coupling in human embryonic stem cell-derived ventricular cardiomyocytes Stem Cells Dev. 19 2010 773 782
7. N.C. Dubois SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells Nat. Biotechnol. 29 2011 1011 1018
8. J. Liu Facilitated maturation of Ca2+ handling properties of human embryonic stem cell-derived cardiomyocytes by calsequestrin expression Am. J. Physiol. Cell Physiol. 297 2009 C152 C159
9. Y. Shiba Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts Nature 489 2012 322 325
10. L. Zwi-Dantsis Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients Eur. Heart J. 2012 [Epub ahead of print]
11. J. Nussbaum Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response FASEB J. 21 2007 1345 1357
12. G. Foldes Modulation of human embryonic stem cell-derived cardiomyocyte growth: a testbed for studying human cardiac hypertrophy? J. Mol. Cell. Cardiol. 50 2011 367 376
13. T. Xue Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers Circulation 111 2005 11 20
14. H. Liang Human and murine embryonic stem cell-derived cardiomyocytes serve together as a valuable model for drug safety screening Cell. Physiol. Biochem. 25 2010 459 466
15. A. Mehta Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells Cardiovasc. Res. 91 2011 577 586
16. L.Q. Wan Geometric control of human stem cell morphology and differentiation Integr. Biol. (Camb.) 2 2010 346 353
17. F. Rehfeldt Hyaluronic acid matrices show matrix stiffness in 2D and 3D dictates cytoskeletal order and myosin-II phosphorylation within stem cells Integr. Biol. (Camb.) 4 2012 422 430
18. J.S. Park The effect of matrix stiffness on the differentiation of mesenchymal stem cells in response to TGF-beta Biomaterials 32 2011 3921 3930
19. J.G. Jacot Substrate stiffness affects the functional maturation of neonatal rat ventricular myocytes Biophys. J. 95 2008 3479 3487
20. K. Shapira-Schweitzer, and D. Seliktar Matrix stiffness affects spontaneous contraction of cardiomyocytes cultured within a PEGylated fibrinogen biomaterial Acta Biomater. 3 2007 33 41
21. G. Vunjak-Novakovic Bioengineering heart muscle: a paradigm for regenerative medicine Annu. Rev. Biomed. Eng. 13 2011 245 267
22. T.P. Kraehenbuehl Three-dimensional biomaterials for the study of human pluripotent stem cells Nat. Methods 8 2011 731 736
23. T. Eschenhagen Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system FASEB J. 11 1997 683 694
24. C. Fink Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement FASEB J. 14 2000 669 679
25. T. Eschenhagen Cardiac tissue engineering Transpl. Immunol. 9 2002 315 321
26. W.H. Zimmermann Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts Nat. Med. 12 2006 452 458
27. T. Shimizu Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces Circ. Res. 90 2002 e40
28. I.A. Memon Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets J. Thorac. Cardiovasc. Surg. 130 2005 1333 1341
29. M. Radisic Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds Proc. Natl. Acad. Sci. U. S. A. 101 2004 18129 18134
30. M. Radisic Medium perfusion enables engineering of compact and contractile cardiac tissue Am. J. Physiol. Heart Circ. Physiol. 286 2004 H507 H516
31. A.N. Morritt Cardiac tissue engineering in an in vivo vascularized chamber Circulation 115 2007 353 360
32. O. Caspi Tissue engineering of vascularized cardiac muscle from human embryonic stem cells Circ. Res. 100 2007 263 272
33. K.R. Stevens Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue Proc. Natl. Acad. Sci. U. S. A. 106 2009 16568 16573
34. N.L. Tulloch Growth of engineered human myocardium with mechanical loading and vascular coculture Circ. Res. 109 2011 47 59
35. S. Schaaf Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology PLoS ONE 6 2011 e26397
36. B. Liau Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function Biomaterials 32 2011 9180 9187
37. P.M. Janssen The trabecula culture system: a novel technique to study contractile parameters over a multiday time period Am. J. Physiol. 274 Pt 2 1998 H1481 H1488
38. K.A. Guterl Isometric contraction induces rapid myocyte remodeling in cultured rat right ventricular papillary muscles Am. J. Physiol. Heart Circ. Physiol. 293 2007 H3707 H3712
39. G.W. Serrao Myocyte-depleted engineered cardiac tissues support therapeutic potential of mesenchymal stem cells Tissue Eng. A 18 2012 1322 1333
40. A. Hansen Development of a drug screening platform based on engineered heart tissue Circ. Res. 107 2010 35 44
41. H. Vandenburgh Drug-screening platform based on the contractility of tissue-engineered muscle Muscle Nerve 37 2008 438 447
42. K. Baar Self-organization of rat cardiac cells into contractile 3-D cardiac tissue FASEB J. 19 2005 275 277
43. S. Hinds The role of extracellular matrix composition in structure and function of bioengineered skeletal muscle Biomaterials 32 2011 3575 3583
44. P.W. Alford Biohybrid thin films for measuring contractility in engineered cardiovascular muscle Biomaterials 31 2010 3613 3621
45. I.J. Domian Generation of functional ventricular heart muscle from mouse ventricular progenitor cells Science 326 2009 426 429
46. R.D. Kirkton, and N. Bursac Engineering biosynthetic excitable tissues from unexcitable cells for electrophysiological and cell therapy studies Nat. Commun. 2 2011 300
47. F.G. Akar Mechanisms underlying conduction slowing and arrhythmogenesis in nonischemic dilated cardiomyopathy Circ. Res. 95 2004 717 725
48. T. Boudou A Microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues Tissue Eng. A 18 2012 910 919
49. W.R. Legant Microfabricated tissue gauges to measure and manipulate forces from 3D microtissues Proc. Natl. Acad. Sci. U. S. A. 106 2009 10097 10102
50. F.J. Sutherland, and D.J. Hearse The isolated blood and perfusion fluid perfused heart Pharmacol. Res. 41 2000 613 627
51. E.J. Lee Engineered cardiac organoid chambers: toward a functional biological model ventricle Tissue Eng. A 14 2008 215 225
52. M. Gonen-Wadmany Controlling the cellular organization of tissue-engineered cardiac constructs Ann. N. Y. Acad. Sci. 1015 2004 299 311
53. Y. Yildirim Development of a biological ventricular assist device: preliminary data from a small animal model (Translated from English) Circulation 116 Suppl 2007 I16 I23 (in English)
54. G.M. Fomovsky, and J.W. Holmes Evolution of scar structure, mechanics, and ventricular function after myocardial infarction in the rat Am. J. Physiol. Heart Circ. Physiol. 298 2010 H221 H228
55. I.D. Greener Connexin43 gene transfer reduces ventricular tachycardia susceptibility after myocardial infarction J. Am. Coll. Cardiol. 60 2012 1103 1110
56. D.C. Paik Nitrite-induced cross-linking alters remodeling and mechanical properties of collagenous engineered tissues Connect. Tissue Res. 47 2006 163 176
57. R. Roy Processing of type I collagen gels using nonenzymatic glycation J. Biomed. Mater. Res. A 93 2010 843 851
58. S. Cosentino Cardiomyocyte death induced by ischaemic/hypoxic stress is differentially affected by distinct purinergic P2 receptors J. Cell. Mol. Med. 16 2012 1074 1084
59. G.M. Fomovsky Regional mechanics determine collagen fiber structure in healing myocardial infarcts J. Mol. Cell. Cardiol. 52 2012 1083 1090
60. E. Kim do Engineered cardiac tissues for in vivo assessment of contractile function and repair mechanisms Conf. Proc. IEEE Eng. Med. Biol. Soc., vol. 1 2006 849 852
61. R. Rossini Prevention of left ventricular remodelling after acute myocardial infarction: an update Recent Pat. Cardiovasc. Drug Discov. 5 2010 196 207
62. A. Nakamura LV systolic performance improves with development of hypertrophy after transverse aortic constriction in mice Am. J. Physiol. Heart Circ. Physiol. 281 2001 H1104 H1112
63. S. Haq Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure Circulation 103 2001 670 677
64. M. Tartaglia, and B.D. Gelb Noonan syndrome and related disorders: genetics and pathogenesis Annu. Rev. Genomics Hum. Genet. 6 2005 45 68
65. X. Carvajal-Vergara Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome Nature 465 2010 808 812
66. F. Pillekamp Contractile properties of early human embryonic stem cell-derived cardiomyocytes: Beta-adrenergic stimulation induces positive chronotropy and lusitropy but not inotropy Stem Cells Dev. 21 2012 2111 2121
67. T. Thum MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure Circulation 116 2007 258 267
68. M.K. Jonsson Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG J. Mol. Cell. Cardiol. 2012